290 related articles for article (PubMed ID: 2902891)
1. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment.
Michel MC; Pingsmann A; Beckeringh JJ; Zerkowski HR; Doetsch N; Brodde OE
Br J Pharmacol; 1988 Jul; 94(3):685-92. PubMed ID: 2902891
[TBL] [Abstract][Full Text] [Related]
2. Chronic beta-adrenoceptor antagonist treatment modulates human cardiac and vascular beta-adrenoceptor density in a subtype-selective fashion.
Brodde OE; Michel MC; Wang XL; Zerkowski HR
J Hypertens Suppl; 1988 Dec; 6(4):S497-500. PubMed ID: 2907348
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte beta 2-adrenoceptors mirror precisely beta 2-adrenoceptor, but poorly beta 1-adrenoceptor changes in the human heart.
Michel MC; Beckeringh JJ; Ikezono K; Kretsch R; Brodde OE
J Hypertens Suppl; 1986 Dec; 4(6):S215-8. PubMed ID: 2886571
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of chronic calcium antagonist treatment on beta 1- and beta 2-adrenoceptors in right atria from patients with or without heart failure.
Brodde OE; Hundhausen HJ; Zerkowski HR; Michel MC
Br J Clin Pharmacol; 1992 Mar; 33(3):269-74. PubMed ID: 1315561
[TBL] [Abstract][Full Text] [Related]
5. Subtype-selective up-regulation of human saphenous vein beta 2-adrenoceptors by chronic beta-adrenoceptor antagonist treatment.
Brodde OE; Zerkowski HR; Doetsch N; Khamssi M
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):479-82. PubMed ID: 2567967
[TBL] [Abstract][Full Text] [Related]
6. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
Juberg EN; Minneman KP; Abel PW
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):193-202. PubMed ID: 2865685
[TBL] [Abstract][Full Text] [Related]
7. Interaction between simvastatin and metoprolol with respect to cardiac beta-adrenoceptor density, catecholamine levels and perioperative catecholamine requirements in cardiac surgery patients.
Nette AF; Abraham G; Ungemach FR; Oertel R; Kirch W; Leineweber K; Mohr FW; Dhein S
Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):115-24. PubMed ID: 16215713
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
[TBL] [Abstract][Full Text] [Related]
9. Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists.
Brodde OE; Daul A; Michel MC
Clin Physiol Biochem; 1990; 8 Suppl 2():11-7. PubMed ID: 1982757
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy.
Brodde OE; Schüler S; Kretsch R; Brinkmann M; Borst HG; Hetzer R; Reidemeister JC; Warnecke H; Zerkowski HR
J Cardiovasc Pharmacol; 1986; 8(6):1235-42. PubMed ID: 2434752
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".
Brodde OE; Daul A; Stuka N; O'Hara N; Borchard U
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):417-22. PubMed ID: 2859531
[TBL] [Abstract][Full Text] [Related]
12. Regulation of beta 1- and beta 2-adrenoceptors following chronic treatment with beta-adrenoceptor antagonists.
Elfellah MS; Reid JL
Eur J Pharmacol; 1989 Nov; 173(1):85-92. PubMed ID: 2575041
[TBL] [Abstract][Full Text] [Related]
13. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
[TBL] [Abstract][Full Text] [Related]
14. Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues.
Buxton BF; Jones CR; Molenaar P; Summers RJ
Br J Pharmacol; 1987 Oct; 92(2):299-310. PubMed ID: 2823947
[TBL] [Abstract][Full Text] [Related]
15. Characterization of rat cerebral cortical beta adrenoceptor subtypes using (-)-[125I]-iodocyanopindolol.
Tiong AH; Richardson JS
J Recept Res; 1989-1990; 9(6):495-508. PubMed ID: 2577008
[TBL] [Abstract][Full Text] [Related]
16. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of beta-adrenoceptor subtypes in rabbit right atria.
Tenner TE; Young JA; Earley KJ; Yen YC
Life Sci; 1989; 44(10):651-60. PubMed ID: 2564611
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of human cardiac beta-adrenergic and muscarinic receptors by chronic beta-adrenoceptor antagonist treatment.
Motomura S; Deighton NM; Zerkowski HR; Khamssi M; Brodde OE
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):112S-114S. PubMed ID: 1980074
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
